… transdermal fentanyl, … abuse potential of buprenorphine in the outpatient setting is
countered by the prescribing of combined delivery of naloxone in 4-to-1 (buprenorphine-to-naloxone) …

… buprenorphine/naloxone quickly stabilized fentanyl users … buprenorphine ER in the community
28 days later. He reports that since receiving buprenorphine ER, he has not used fentanyl …

… The increasing prevalence of high-potency illicit opioids, such as fentanyl and fentanyl
analogues, … It is possible that high-dose induction using a combination buprenorphine-naloxone …

… or the opioid antagonists naltrexone and naloxone [12]. … buprenorphine was started within
48 h of last fentanyl use compared to starting buprenorphine within 48 h of last methadone use …

… with naloxone. A diminished risk of diversion and abuse for the buprenorphine–naloxone …
of other opioids, including methadone, buprenorphine (BUP), oxycodone, and fentanyl. …

… opiates, including morphine, oxycodone, fentanyl, methadone and its metabolite (EDDP),
tramadol, buprenorphine, as well as for other common drugs used for non-medical purposes or …

… repeated fentanyl use might necessitate higher doses of methadone or buprenorphine than
… shorter duration of the action of naloxone (t 1/2 : 1.3‐2.4 hours) than that of fentanyl (t 1/2 : 7 …

… fentanyl analogs that are used as adulterants of the illicit drug supply and in counterfeit tablets.
It does not address fentanyl … This observation has been attributed to buprenorphine’s high …

… mono-buprenorphine for cost or medical (such as pregnancy or sensitivity to naloxone) …
This is particularly important given the increasing presence of fentanyl, which may make it …

… , the ability of naloxone to reverse buprenorphine-induced … of transdermal fentanyl and
transdermal buprenorphine in … using ratios of 1:100 and 1:75 for fentanyl and buprenorphine, …